Nutrition and the risk of stroke

The Lancet Neurology

Volumn 11, Issue 1, 2012, Pages 66-81

  Hankey, Graeme J ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CALCIUM; CARBOHYDRATE; COLECALCIFEROL; COPPER; CYANOCOBALAMIN; FAT; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; POTASSIUM; PROTEIN; PYRIDOXINE; RETINOL; SATURATED FATTY ACID; SELENIUM; SERUM ALBUMIN; SODIUM CHLORIDE; SWEETENING AGENT; TRANS FATTY ACID; VITAMIN D;

AGE; ARTERY DISEASE; ARTERY EMBOLISM; BEAN; BEVERAGE; BODY MASS; BODY WEIGHT; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BUTTER; CACAO; CALCIUM INTAKE; CARBOHYDRATE DIET; CEREAL; CHEESE; CHICKPEA; CHILDHOOD DISEASE; COFFEE; DIABETES MELLITUS; DIET; DIET SUPPLEMENTATION; DIETARY APPROACHES TO STOP HYPERTENSION DIET; DIETARY INTAKE; FAT INTAKE; FETUS GROWTH; FISH MEAT; FRUIT; GENETIC RISK; GLUCOSE BLOOD LEVEL; GRAIN; HEAD CIRCUMFERENCE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE DIET; KIDNEY DISEASE; LENTIL; LIPID BLOOD LEVEL; LIPID OXIDATION; LOW BIRTH WEIGHT; MALNUTRITION; MATERNAL HYPERTENSION; MATERNAL NUTRITION; MEAT; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); MILK; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OVERNUTRITION; PEA; PLACENTA DEVELOPMENT; POTASSIUM INTAKE; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN INTAKE; PRUDENT DIET; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; RICE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SALT INTAKE; SODIUM RESTRICTION; STROKE; SUBARACHNOID HEMORRHAGE; SUGAR INTAKE; SYSTOLIC BLOOD PRESSURE; TEA; VEGETABLE; VEGETARIAN DIET; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE; WEIGHT GAIN;

HUMANS; MALNUTRITION; NUTRITIONAL STATUS; RISK FACTORS; STROKE;

EID: 83455249805     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70265-4     Document Type: Review

References (185)

1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8:355-369.
2. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010, 121:586-613. the American Heart Association Strategic Planning Task Force and Statistics Committee.
3. Lock K, Smith RD, Dangour AD, et al. Health, agricultural, and economic effects of adoption of healthy diet recommendations. Lancet 2010, 376:1699-1709.
4. Dans A, Ng N, Varghese C, Tai ES, Firestone R, Bonita R The rise of chronic non-communicable diseases in southeast Asia: time for action. Lancet 2011, 377:680-689.
5. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011, 378:804-814.
6. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011, 378:815-825.
7. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011, 377:557-567. the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index).
8. Strong K, Mathers C, Bonita R Preventing stroke: saving lives around the world. Lancet Neurol 2007, 6:182-187.
9. Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 2010, 376:1775-1784.
10. Franklin BA, Cushman M Recent advances in preventive cardiology and lifestyle medicine: a themed series. Circulation 2011, 123:2274-2283.
11. Sacco RL Achieving ideal cardiovascular and brain health: opportunity amid crisis: Presidential Address at the American Heart Association 2010 Scientific Sessions. Circulation 2011, 123:2653-2657.
12. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:517-584. the American Heart Association Stroke Council, and the Council on Cardiovascular Nursing, and the Council on Epidemiology and Prevention, and the Council for High Blood Pressure Research, and the Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research.
13. Saunders J, Smith T Malnutrition: causes and consequences. Clin Med 2010, 10:624-627.
14. Foley NC, Salter KL, Robertson J, Teasell RW, Woodbury MG Which reported estimate of the prevalence of malnutrition after stroke is valid?. Stroke 2009, 40:e66-e74.
15. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998, 68:899-917. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary.
16. Deurenberg P, Yap M, van Staveren WA Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998, 22:1164-1171.
17. Bodenant M, Kuulasmaa K, Wagner A, et al. Measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. Stroke 2011, 42:2872-2877. the MORGAM Project.
18. Gariballa SE, Parker SG, Taub N, Castleden M Nutritional status of hospitalized acute stroke patients. Br J Nutr 1998, 79:481-487.
19. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 2003, 14:2623-2631.
20. Gao C, Zhang B, Zhang W, Pu S, Yin J, Gao Q Serum prealbumin (transthyretin) predict good outcome in young patients with cerebral infarction. Clin Exp Med 2011, 11:49-54.
21. Elia M, Stratton RJ How much undernutrition is there in hospitals?. Br J Nutr 2000, 84:257-259.
22. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
23. Ogden CL, Carroll MD, Flegal KM High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008, 299:2401-2405.
24. Wang Y, Beydoun MA The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007, 29:6-28.
25. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490. the GRADE Working Group.
26. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926. the GRADE Working Group.
27. Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?. Lancet 2004, 363:1724-1727.
28. Hill AB The environment and disease: association or causation?. Proc R Soc Med 1965, 58:295-300.
29. Mente A, de Koning L, Shannon HS, Anand SS A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009, 169:659-669.
30. Martyn CN, Barker DJP, Osmond C Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 1996, 348:1264-1268.
31. Osmond C, Kajantie E, Forsén TJ, Eriksson JG, Barker DJP Infant growth and stroke in adult life: the Helsinki birth cohort study. Stroke 2007, 38:264-270.
32. Eriksson JG, Forsén T, Tuomilehto J, Osmond C, Barker DJ Early growth, adult income, and risk of stroke. Stroke 2000, 31:869-874.
33. Barker DJP, Lackland DT Prenatal influences on stroke mortality in England and Wales. Stroke 2003, 34:1598-1602.
34. Glymour MM, Avendaño M, Berkman LF Is the 'stroke belt' worn from childhood?: risk of first stroke and state of residence in childhood and adulthood. Stroke 2007, 38:2415-2421.
35. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. the Prospective Studies Collaboration.
36. Yatsuya H, Folsom AR, Yamagishi K, North KE, Brancati FL, Stevens J Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010, 41:417-425. the Atherosclerosis Risk in Communities Study Investigators.
37. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002, 162:2557-2562.
38. Kurth T, Gaziano JM, Rexrode KM, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005, 111:1992-1998.
39. Song Y-M, Sung J, Davey Smith G, Ebrahim S Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke 2004, 35:831-836.
40. Ni Mhurchu C, Rodgers A, Pan WH, Gu DF, Woodward M Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol 2004, 33:751-758. the Asia Pacific Cohort Studies Collaboration.
41. Winter Y, Rohrmann S, Linseisen J, et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 2008, 39:3145-3151.
42. Furukawa Y, Kokubo Y, Okamura T, et al. The relationship between waist circumference and the risk of stroke and myocardial infarction in a Japanese urban cohort: the Suita study. Stroke 2010, 41:550-553.
43. Saito I, Iso H, Kokubo Y, Inoue M, Tsugane S Body mass index, weight change and risk of stroke and stroke subtypes: the Japan Public Health Center-based prospective (JPHC) study. Int J Obes (Lond) 2011, 35:283-291.
44. Kizer JR, Biggs ML, Ix JH, et al. Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol 2011, 173:10-25.
45. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123. the INTERSTROKE investigators.
46. Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011, 377:1085-1095. the Emerging Risk Factors Collaboration.
47. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007, 297:842-857.
48. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003, 361:2017-2023.
49. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:23-33. Heart Protection Study Collaborative Group.
50. Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007, 167:1610-1618.
51. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
52. Bin Q, Hu X, Cao Y, Gao F The role of vitamin E (tocopherol) supplementation in the prevention of stroke. A meta-analysis of 13 randomised controlled trials. Thromb Haemost 2011, 105:579-585.
53. Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 2010, 170:1622-1631. the B-Vitamin Treatment Trialists' Collaboration.
54. Holmes MV, Newcombe P, Hubacek JA, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 2011, 378:584-594.
55. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152:307-314.
56. Wang L, Manson JE, Song Y, Sesso HD Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010, 152:315-323.
57. Manson JE Vitamin D and the heart: why we need large-scale clinical trials. Cleve Clin J Med 2010, 77:903-910.
58. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio FP Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009, 339:b4567.
59. He FJ, MacGregor GA Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011, 378:380-382.
60. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens 2011, 24:843-853.
61. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009, 54:475-481.
62. Sacks FM, Campos H Dietary therapy in hypertension. N Engl J Med 2010, 362:2102-2112.
63. Webster JL, Dunford EK, Hawkes C, Neal BC Salt reduction initiatives around the world. J Hypertens 2011, 29:1043-1050.
64. MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet 1989, 2:1244-1247.
65. Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001, 135:1019-1028. the DASH-Sodium Trial Collaborative Research Group.
66. Larsson SC, Orsini N, Wolk A Dietary potassium intake and risk of stroke: a dose-response meta-analysis of prospective studies. Stroke 2011, 42:2746-2750.
67. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997, 277:1624-1632.
68. Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006, 3. CD004641.
69. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010, 341:c3691.
70. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011, 342:d2040.
71. He K, Merchant A, Rimm EB, et al. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ 2003, 327:777-782.
72. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295:655-666.
73. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010, 91:535-546.
74. Marik PE, Varon J Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009, 32:365-372.
75. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010, 341:c6273. the SU.FOL.OM3 Collaborative Group.
76. de Goede J, Verschuren WMM, Boer JMA, Kromhout D, Geleijnse JM Alpha-linolenic acid intake and 10-year incidence of coronary heart disease and stroke in 20,000 middle-aged men and women in the Netherlands. PLoS One 2011, 6:e17967. 10.1371/journal.pone.0017967.
77. Livesey G, Taylor R, Hulshof T, Howlett J Glycemic response and health: a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr 2008, 87:258S-268S.
78. Oba S, Nagata C, Nakamura K, et al. Dietary glycemic index, glycemic load, and intake of carbohydrate and rice in relation to risk of mortality from stroke and its subtypes in Japanese men and women. Metabolism 2010, 59:1574-1582.
79. Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 2005, 23:475-481.
80. Preis SR, Stampfer MJ, Spiegelman D, Willett WC, Rimm EB Lack of association between dietary protein intake and risk of stroke among middle-aged men. Am J Clin Nutr 2010, 91:39-45.
81. Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 2004, 45:993-1007.
82. Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw K-T Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study. Am J Clin Nutr 2008, 87:64-69.
83. Kubota Y, Iso H, Date C, the JACC study group, et al. Dietary intakes of antioxidant vitamins and mortality from cardiovascular disease: the Japan Collaborative Cohort Study (JACC) study. Stroke 2011, 42:1665-1672.
84. Clarke MW, Burnett JR, Croft KD Vitamin E in human health and disease. Crit Rev Clin Lab Sci 2008, 45:417-450.
85. Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010, 341:c5702.
86. Wald DS, Wald NJ, Morris JK, Law M Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 2006, 333:1114-1117.
87. Hassan A, Hunt BJ, O'Sullivan M, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004, 127:212-219.
88. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000, 31:1069-1075.
89. Poli D, Antonucci E, Cecchi E, et al. Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke 2005, 36:2159-2163.
90. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005, 82:806-812. Homocysteine Lowering Trialists' Collaboration.
91. Flicker L, Vasikaran SD, Thomas J, et al. Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia. Stroke 2006, 37:547-549.
92. Spence JD, Bang H, Chambless LE, Stampfer MJ Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke 2005, 36:2404-2409.
93. Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567-1577. the Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators.
94. Deshmukh US, Joglekar CV, Lubree HG, et al. Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India. Eur J Clin Nutr 2010, 64:495-502.
95. Carrelli AL, Walker MD, Lowe H, et al. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke 2011, 42:2240-2245.
96. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD The effect of vitamin D replacement on markers of vascular health in stroke patients-a randomised controlled trial. Nutr Metab Cardiovasc Dis 2010, published online Dec 29. 10.1016/j.numecd.2010.11.001.
97. Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med 2011, 171:1625-1633.
98. Jamrozik K, Broadhurst RJ, Anderson CS, Stewart-Wynne EG The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia. Stroke 1994, 25:51-59.
99. Frohlich ED The salt conundrum: a hypothesis. Hypertension 2007, 50:161-166.
100. He FJ, MacGregor GA Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002, 16:761-770.
101. He FJ, MacGregor GA Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension 2006, 48:861-869.
102. D'Elia L, Barba G, Cappuccio FP, Strazzullo P Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol 2011, 57:1210-1219.
103. Sambrook P, Cooper C Osteoporosis. Lancet 2006, 367:2010-2018.
104. Tang BMP, Eslick GD, Nowson C, Smith C, Bensoussan A Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007, 370:657-666.
105. Griffith LE, Guyatt GH, Cook RJ, Bucher HC, Cook DJ The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens 1999, 12:84-92.
106. Reid IR, Horne A, Mason B, Ames R, Bava U, Gamble GD Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab 2005, 90:3824-3829.
107. Reid IR, Mason B, Horne A, et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 2002, 112:343-347.
108. Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 1999, 30:1772-1779.
109. Umesawa M, Iso H, Ishihara J, et al. Dietary calcium intake and risks of stroke, its subtypes, and coronary heart disease in Japanese: the JPHC Study Cohort I. Stroke 2008, 39:2449-2456. the JPHC Study Group.
110. Larsson SC, Virtamo J, Wolk A Potassium, calcium, and magnesium intakes and risk of stroke in women. Am J Epidemiol 2011, 174:35-43.
111. Abrahamsen B, Sahota O Do calcium plus vitamin D supplements increase cardiovascular risk?. BMJ 2011, 342:d2080.
112. Christensen S, Mehnert F, Chapurlat RD, Baron JA, Sørensen HT Oral bisphosphonates and risk of ischemic stroke: a case-control study. Osteoporos Int 2011, 22:1773-1779.
113. Mozaffarian D, Appel LJ, Van Horn L Components of a cardioprotective diet: new insights. Circulation 2011, 123:2870-2891.
114. Jakobsen MU, O'Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425-1432.
115. Mozaffarian D, Aro A, Willett WC Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009, 63(suppl 2):S5-21.
116. Mozaffarian D, Stampfer MJ Removing industrial trans fat from foods. BMJ 2010, 340:c1826.
117. Micha R, Mozaffarian D Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010, 45:893-905.
118. Mozaffarian D, Micha R, Wallace S Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7:e1000252.
119. Saravanan P, Davidson NC, Schmidt EB, Calder PC Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010, 376:540-550.
120. Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009, 120:1011-1020. the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism and the Council on Epidemiology and Prevention.
121. Sieri S, Krogh V, Berrino F, et al. Dietary glycemic load and index and risk of coronary heart disease in a large italian cohort: the EPICOR study. Arch Intern Med 2010, 170:640-647.
122. Jakobsen MU, Dethlefsen C, Joensen AM, et al. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 2010, 91:1764-1768.
123. Sauvaget C, Nagano J, Hayashi M, Yamada M Animal protein, animal fat, and cholesterol intakes and risk of cerebral infarction mortality in the adult health study. Stroke 2004, 35:1531-1537.
124. Larsson SC, Orsini N Fish consumption and risk of stroke. A dose-response meta-analysis. Stroke 2011, published online Sept 8. 10.1161/STROKEAHA.111.630319.
125. He FJ, Nowson CA, MacGregor GA Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006, 367:320-326.
126. John JH, Ziebland S, Yudkin P, Roe LS, Neil HAW Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002, 359:1969-1974. the Oxford Fruit and Vegetable Study Group.
127. Micha R, Wallace SK, Mozaffarian D Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 2010, 121:2271-2283.
128. Larsson SC, Virtamo J, Wolk A Red meat consumption and risk of stroke in Swedish men. Am J Clin Nutr 2011, 94:417-421.
129. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr 2011, 93:158-171.
130. Buitrago-Lopez A, Sanderson J, Johnson L, et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 2011, 343:d4488.
131. Larsson SC, Orsini N Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 2011, 174:993-1001.
132. Larsson SC, Virtamo J, Wolk A Coffee consumption and risk of stroke in women. Stroke 2011, 42:908-912.
133. Arab L, Liu W, Elashoff D Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009, 40:1786-1792.
134. Chen L, Appel LJ, Loria C, et al. Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial. Am J Clin Nutr 2009, 89:1299-1306.
135. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010, 33:2477-2483.
136. Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr 2009, 89:1037-1042.
137. Mellen PB, Walsh TF, Herrington DM Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2008, 18:283-290.
138. Eshak ES, Iso H, Date C, et al. Rice intake is associated with reduced risk of mortality from cardiovascular disease in Japanese men but not women. J Nutr 2011, 141:595-602. the JACC Study Group.
139. Myint PK, Welch AA, Bingham SA, et al. Habitual fish consumption and risk of incident stroke: the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study. Public Health Nutr 2006, 9:882-888.
140. Atkinson C, Whitley E, Ness A, Baker I Associations between types of dietary fat and fish intake and risk of stroke in the Caerphilly Prospective Study (CaPS). Public Health 2011, 125:345-348.
141. Larsson SC, Virtamo J, Wolk A Fish consumption and risk of stroke in Swedish women. Am J Clin Nutr 2011, 93:487-493.
142. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001, 285:304-312.
143. Bouzan C, Cohen JT, Connor WE, et al. A quantitative analysis of fish consumption and stroke risk. Am J Prev Med 2005, 29:347-352.
144. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84:5-17.
145. Mozaffarian D, Wu JHY Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011, 58:2047-2067.
146. Goldbohm RA, Chorus AM, Schouten LJ, van den Brandt PA Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr 2011, 93:615-627. Galindo Garre F.
147. Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 2011, 94:1113-1126.
148. Mostofsky E, Schlaug G, Mukamal KJ, Rosamond WD, Mittleman MA Coffee and acute ischemic stroke onset: the Stroke Onset Study. Neurology 2010, 75:1583-1588.
149. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008, 88:38-50.
150. Jochmann N, Lorenz M, Krosigk A, et al. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 2008, 99:863-868.
151. Tinahones FJ, Rubio MA, Garrido-Sánchez L, et al. Green tea reduces LDL oxidability and improves vascular function. J Am Coll Nutr 2008, 27:209-213.
152. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008, 88:38-50.
153. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044. the American Heart Association Nutrition Committee.
154. Kurth T, Moore SC, Gaziano JM, et al. Healthy lifestyle and the risk of stroke in women. Arch Intern Med 2006, 166:1403-1409.
155. Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB Primary prevention of stroke by healthy lifestyle. Circulation 2008, 118:947-954.
156. Fung TT, Stampfer MJ, Manson JE, Rexrode KM, Willett WC, Hu FB Prospective study of major dietary patterns and stroke risk in women. Stroke 2004, 35:2014-2019.
157. Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 2008, 168:713-720.
158. Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009, 119:1093-1100.
159. Yau WY, Hankey GJ Which dietary and lifestyle behaviours may be important in the aetiology (and prevention) of stroke?. J Clin Neurosci 2011, 18:76-80.
160. Sofi F, Abbate R, Gensini GF, Casini A Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010, 92:1189-1196.
161. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997, 336:1117-1124. the DASH Collaborative Research Group.
162. Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145:1-11. for the PREDIMED Study Investigators.
163. Fitó M, Guxens M, Corella D, et al. Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med 2007, 167:1195-1203. the for the PREDIMED Study Investigators.
164. Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008, 359:229-241. the Dietary Intervention Randomized Controlled Trial (DIRECT) Group.
165. Sciarrone SE, Strahan MT, Beilin LJ, Burke V, Rogers P, Rouse IR Ambulatory blood pressure and heart rate responses to vegetarian meals. J Hypertens 1993, 11:277-285.
166. Burke LE, Hudson AG, Warziski MT, et al. Effects of a vegetarian diet and treatment preference on biochemical and dietary variables in overweight and obese adults: a randomized clinical trial. Am J Clin Nutr 2007, 86:588-596.
167. Key TJ, Fraser GE, Thorogood M, et al. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr 1998, 1:33-41.
168. Willcox BJ, Willcox DC, Todoriki H, et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci 2007, 1114:434-455.
169. Willcox DC, Willcox BJ, Todoriki H, Suzuki M The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load. J Am Coll Nutr 2009, 28(suppl):500S-516S.
170. Oba S, Nagata C, Nakamura K, et al. Dietary glycemic index, glycemic load, and intake of carbohydrate and rice in relation to risk of mortality from stroke and its subtypes in Japanese men and women. Metabolism 2010, 59:1574-1582.
171. Tada N, Maruyama C, Koba S, et al. Japanese dietary lifestyle and cardiovascular disease. J Atheroscler Thromb 2011, 18:723-734.
172. Shimazu T, Kuriyama S, Hozawa A, et al. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int J Epidemiol 2007, 36:600-609.
173. Iso H Lifestyle and cardiovascular disease in Japan. J Atheroscler Thromb 2011, 18:83-88.
174. Hawkes N Take dietary truths with a pinch of salt. BMJ 2011, 343:d5346.
175. King D The future challenge of obesity. Lancet 2011, 378:743-744.
176. Cappuccio FP, Capewell S, Lincoln P, McPherson K Policy options to reduce population salt intake. BMJ 2011, 343:d4995.
177. Campbell NRC, Legowski B, Legetic B Mobilising the Americas for dietary salt reduction. Lancet 2011, 377:793-795.
178. Kopelman P Symposium 1: Overnutrition: consequences and solutions. Foresight Report: the obesity challenge ahead. Proc Nutr Soc 2010, 69:80-85.
179. Gortmaker SL, Swinburn BA, Levy D, et al. Changing the future of obesity: science, policy, and action. Lancet 2011, 378:838-847.
180. Mozaffarian D, Capewell SU United Nations' dietary policies to prevent cardiovascular disease. BMJ 2011, 343:d5747.
181. He FJ, MacGregor GA A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009, 23:363-384.
182. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010, 362:590-599.
183. Appel LJ, Frohlich ED, Hall JE, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 2011, 123:1138-1143.
184. Lock K, Smith RD, Dangour AD, et al. Health, agricultural, and economic effects of adoption of healthy diet recommendations. Lancet 2010, 376:1699-1709.
185. Capewell S, O'Flaherty M Rapid mortality falls after risk-factor changes in populations. Lancet 2011, 378:752-753.